A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Clinical trial NCT06800339 · RECRUITING
Trial details
- NCT number
- NCT06800339
- Sponsor
- University of Maryland, Baltimore
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2028-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.